Core Viewpoint - Yifeng New Materials Co., Ltd. has submitted its prospectus to the Shenzhen Stock Exchange's ChiNext after withdrawing its application for the Sci-Tech Innovation Board four years ago, despite facing a decline in revenue over three consecutive years from 2022 to 2024 [1][2]. Company Background and Core Risks - Established in 2011, Yifeng New Materials specializes in the research, production, and sales of sulfides, with the actual controllers holding a combined 49.96% stake. However, the company faces two significant inherent risks: a fragile core business and a heavy reliance on related parties [3][5]. - The global market size for its core product, thiourea, is projected to be approximately 851 million yuan in 2024, indicating limited growth potential despite holding a 26% market share. The company has attempted to pivot to optical new materials, but this segment contributes less than 30% of total revenue, highlighting its dependence on a declining traditional market [5][6]. IPO Journey and Underwriter Relationships - Yifeng New Materials has faced challenges in its capital journey, having previously attempted an IPO on the Sci-Tech Innovation Board in November 2021, which ended in withdrawal. The current attempt on the ChiNext marks its second effort [7]. - The underwriting firm for this IPO is Zhongtai Securities, which has a long-standing relationship with the controlling shareholders, raising questions about the independence and diligence of the underwriting process [10]. Governance, Operations, and Business Issues - The company has a complex history of shareholding, with the actual controller previously using up to 35 named shareholders for shareholding representation, reflecting governance issues and a lack of transparency. Additionally, a suspicious low-price share transfer occurred just before the IPO, warranting regulatory scrutiny [11]. - Significant turnover in the core management team in 2023 coincided with a decline in revenue, raising concerns about the stability of the company's strategic direction and operational effectiveness [12]. - The reported increase in gross margin from 34.98% to 39.49% is attributed to the divestiture of low-margin auxiliary businesses rather than genuine improvements in core product competitiveness, casting doubt on the sustainability of this margin enhancement [13][14]. Financial Data and Anomalies - The latest financial data in the prospectus reveals several concerning details beyond revenue decline, indicating potential underlying issues with operational quality and financial health [15]. Historical Issues and Regulatory Concerns - The company's historical reliance on related-party transactions and shareholding complexities have cast a shadow over its current IPO efforts. Regulatory bodies have previously scrutinized the company's pricing and sales practices, particularly regarding its foreign sales revenue [16]. Conclusion - The situation surrounding Yifeng New Materials presents a complex picture of unresolved governance issues, declining business performance, and financial anomalies. Investors and regulators are encouraged to look beyond the company's claimed global market share and critically assess its governance, business sustainability, and the implications of its financial data [17].

Core Viewpoint - Yifeng New Materials Co., Ltd. has initiated its IPO process on the ChiNext board, focusing on organic sulfur chemical products and sulfur-based new materials, with significant funding allocated for various projects aimed at enhancing its production capabilities and R&D efforts [1][4]. Group 1: Company Overview - Yifeng New Materials specializes in the organic sulfur chemical industry, with a primary focus on optical new materials, expecting 85.23% of its revenue in 2024 to come from organic sulfur chemicals and sulfur-based new materials [1]. - The company has achieved several domestic firsts in optical technology and has successfully localized key materials such as polysulfide alcohols [1][9]. - The company is recognized as a national champion in manufacturing and a "little giant" enterprise in specialized and innovative sectors [1]. Group 2: Financial Projections - The company anticipates raising 844.26 million yuan, with major allocations including 419 million yuan for high refractive index optical resin materials, 138 million yuan for high-end functional materials, and 134 million yuan for R&D center construction [1][3]. - Projected revenues for 2024 are 602 million yuan, with net profits expected to reach 139 million yuan [4][5]. - The company has shown a steady increase in net profit from 135 million yuan in 2022 to 139 million yuan in 2024, despite a slight decline in revenue [4]. Group 3: Market Position - Yifeng New Materials holds a 26.40% market share in the global thiourea market, which is projected to be worth 851 million yuan in 2024 [6]. - The company also commands a 5.33% share in the global polysulfide curing agent market, valued at approximately 992 million yuan in 2024 [7]. Group 4: R&D and Innovation - The company has invested a total of 68.26 million yuan in R&D over the past three years, with R&D expenses constituting 2.64% to 4.37% of its revenue during this period [8]. - Yifeng New Materials has developed multiple domestic first processes in the optical field and has led the drafting of several international and industry standards [9]. - The company holds 148 domestic invention patents and has made significant advancements in the industrialization of polysulfide materials, reducing reliance on imports [9]. Group 5: Shareholding Structure - The controlling shareholders, Ma Yunsheng and Wan Chunling, collectively hold 49.96% of the company's shares, ensuring significant influence over corporate decisions [10]. - The shareholding structure has remained stable, with Ma Yunsheng consistently holding a majority stake over the past two years [10].

Core Viewpoint - Yifeng New Materials Co., Ltd. is facing scrutiny over its corporate governance and compliance with information disclosure due to recent low-priced share transfers and historical equity holding arrangements before its IPO [1][2]. Group 1: Share Transfer and Equity Holding - Prior to its IPO, Yifeng New Materials' shareholder Yikun Partnership transferred 246,000 shares to the actual controller Wan Chunling at a price of 10 RMB per share, raising questions about the reasonableness of the pricing compared to previous transfers [2][3]. - Historical analysis reveals that Yifeng New Materials has engaged in multiple equity holding arrangements, including a significant transfer of shares to 63 shareholders, with actual control remaining with hidden shareholders like Wan Chunling [3][4]. - The company previously denied any equity holding arrangements in response to inquiries from the Shanghai Stock Exchange, despite evidence of such practices [2][3]. Group 2: Financial Performance - Yifeng New Materials has experienced a decline in revenue over the past three years, with revenues of 710 million RMB, 630 million RMB, and 600 million RMB for 2022, 2023, and 2024 respectively, reflecting year-on-year decreases of 12.4% and 3.8% [7]. - The company’s net profit remained stable at 140 million RMB across the same period, indicating a slight growth despite revenue decline [7]. - The decline in revenue is attributed to the divestiture of its additive business, which has led to an increase in gross margin from 35.28% in 2022 to 38.33% in 2024 [7][8]. Group 3: Business Composition and Margins - The company’s product mix shows that high-margin sulfur-based materials still represent a low proportion of total revenue, while lower-margin organic sulfur chemical products account for nearly 60% of revenue [8][9]. - The gross margin for the highest-margin product, Poly Sulfide 504, is projected to increase to 63.2% by 2024, indicating a shift towards more profitable products [8]. - The company’s foreign sales have historically had higher gross margins compared to domestic sales, with foreign sales gross margin at 37.05% compared to 23.69% for domestic sales [9].

Core Viewpoint - Yifeng New Materials Co., Ltd. has submitted its IPO application to the Shenzhen Stock Exchange, aiming to raise 844 million yuan for various projects, including high-refractive optical resin materials and digital construction [1][4]. Company Overview - Yifeng New Materials, formerly known as Shandong Yifeng Biochemical Environmental Protection Co., Ltd., changed its name in November 2021 after withdrawing its previous IPO application for the Sci-Tech Innovation Board [3]. - The company focuses on organic sulfur chemistry and optical new materials, producing key products such as thiourea and polysulfide materials [6][10]. Financial Performance - The company reported a decline in revenue from 714 million yuan in 2022 to 625 million yuan in 2023, with a further drop to 602 million yuan in 2024 [15][16]. - The net profit for the years 2022, 2023, and 2024 was approximately 135 million yuan, 137 million yuan, and 139 million yuan, respectively, indicating minimal growth [17]. Investment Projects - The planned investment projects include: - High-refractive optical resin materials project: 419.26 million yuan - High-end functional materials cyclic olefin project: 137.97 million yuan - R&D center construction project: 134.48 million yuan - Digital construction project: 112.88 million yuan - Marketing channel construction project: 39.67 million yuan [5]. Market Position - Yifeng New Materials holds a 5.33% market share in the global polysulfide curing agent market, with an estimated market size of 992 million yuan in 2024 [8]. - The company is a leading producer of thiourea, with a 26.40% market share in a global market valued at approximately 851 million yuan in 2024 [8]. Shareholding Structure - The major shareholders include Ma Yunsheng (32.45%) and Wan Chunling (12.66%), with the Ma family collectively holding nearly 50% of the company [23][24]. - The company has undergone shareholding changes, including instances of shareholding representation, which have been resolved [22][23]. R&D and Innovation - Yifeng New Materials has invested in R&D, with expenses of 22.07 million yuan in 2024, representing 3.67% of its revenue [22]. - The company holds 148 domestic patents and has participated in setting international standards for thiourea [21].